Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation.
about
Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infectionPlatelet lipidomics: modern day perspective on lipid discovery and characterization in plateletsOxidized PLs and vascular inflammationBiosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acidFunctional and pathological roles of the 12- and 15-lipoxygenasesLipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipidsHuman Platelets Utilize Cycloxygenase-1 to Generate Dioxolane A3, a Neutrophil-activating EicosanoidNovel keto-phospholipids are generated by monocytes and macrophages, detected in cystic fibrosis, and activate peroxisome proliferator-activated receptor-γ.Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation.Thrombin-activated human platelets acutely generate oxidized docosahexaenoic-acid-containing phospholipids via 12-lipoxygenase.Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapiesEnzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease.Discovery of potent and selective inhibitors of human platelet-type 12- lipoxygenase.Chronic alcohol exposure increases circulating bioactive oxidized phospholipids.Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitisA novel role for 12/15-lipoxygenase in regulating autophagyTargeted lipidomic strategies for oxygenated metabolites of polyunsaturated fatty acids.Protein kinase C regulation of 12-lipoxygenase-mediated human platelet activation.Formation and signaling actions of electrophilic lipidsA simplified procedure for semi-targeted lipidomic analysis of oxidized phosphatidylcholines induced by UVA irradiation.Oxidatively truncated phospholipids are required agents of tumor necrosis factor α (TNFα)-induced apoptosis.12(S)-HETrE, a 12-Lipoxygenase Oxylipin of Dihomo-γ-Linolenic Acid, Inhibits Thrombosis via Gαs Signaling in PlateletsNew families of bioactive oxidized phospholipids generated by immune cells: identification and signaling actions.Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.LipidFinder: A computational workflow for discovery of lipids identifies eicosanoid-phosphoinositides in platelets.Investigations of human platelet-type 12-lipoxygenase: role of lipoxygenase products in platelet activation.Characterization of platelet aminophospholipid externalization reveals fatty acids as molecular determinants that regulate coagulationMapping the Human Platelet Lipidome Reveals Cytosolic Phospholipase A2 as a Regulator of Mitochondrial Bioenergetics during Activation.Human platelets generate phospholipid-esterified prostaglandins via cyclooxygenase-1 that are inhibited by low dose aspirin supplementation.Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation.DioxolaneA3-phosphatidylethanolamines are generated by human platelets and stimulate neutrophil integrin expression.Synthesis and structure-activity relationship studies of 4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenaseEsterified eicosanoids: generation, characterization and function.Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivationRole of phospholipid oxidation products in atherosclerosis.The role of mid-chain hydroxyeicosatetraenoic acids in the pathogenesis of hypertension and cardiac hypertrophy.Who is the real 12-HETrE?The expansive role of oxylipins on platelet biology.Combined Quantification of the Global Proteome, Phosphoproteome, and Proteolytic Cleavage to Characterize Altered Platelet Functions in the Human Scott Syndrome.Membrane-dependent Activities of Human 15-LOX-2 and Its Murine Counterpart: IMPLICATIONS FOR MURINE MODELS OF ATHEROSCLEROSIS
P2860
Q24604441-86589DA2-2659-4B0F-AC28-2AE68FE6DE06Q26998976-A31CD09D-A640-4D41-93C5-035B8A85D186Q27013971-C845447A-FCBF-4DBB-86A9-A9B91B523BBAQ28252674-DBA7A3D0-C260-47CF-A09D-FF46DEAE30EEQ28296453-1D0C687D-0D84-4C00-B05B-51C5C236D5C4Q28389004-84879B30-C5CE-474A-9167-516386CD67E3Q28829076-3E99AE80-4573-48A9-9137-108B0EBA5849Q30573092-832130EB-F3C9-41F3-A948-46B5F1B0514FQ33416935-7E73456B-D78C-4209-99C0-35D123A2F4B4Q33638866-6993171B-D286-49E2-9EB4-B0829EDC642AQ33662463-34726C88-AE49-4C05-8766-88E9DDC76A73Q33886520-8E689E3C-4CCC-44B5-B89E-8861031850BCQ33955652-375D2C89-EC22-4C11-97FE-C6207894F232Q33991026-4273FC7E-18C9-48B9-ADF6-BCE5D6A3B591Q34636261-F9FA2495-F147-4135-ABAB-BC55CB6A8DD5Q35024517-A27DF616-0558-4CAA-81D1-FCCE1EC32B42Q35070934-8DF7AD50-4A6C-44E1-AE38-8CF23FC24D2DQ35776733-3A30235C-C316-4BEA-A2EB-91C25A788A12Q35804051-302C4125-7812-4B5B-8E82-0A496615372FQ35958509-9E8BD15E-6133-4E34-9EC5-F1B4ACBAFAB8Q36006794-F826A7BF-9221-44F9-BE2C-00E6A3BEFF8BQ36089173-E5506B0C-C640-44F0-B384-8F61036AE19AQ36220711-3AC6F7DE-AC5A-4B9B-BAB5-59FB229CB638Q36322931-81428420-62A4-4932-91B9-CC96CE890544Q36345572-F05DA456-59CC-4C9B-83CD-00BFF41586EFQ36387226-AC966628-F1C6-4D29-A72A-54A0DA07264CQ36762529-6D08990F-F5EC-4A87-8433-7E89A2531124Q36918686-AC3FA88A-F419-4AA0-9FD3-2B59630EEB5AQ37222686-BBA3E79D-0341-480F-A4A3-8CBE6AC7FBD2Q37296539-CD477CAB-61CA-4091-AFD4-CBEF43E96505Q37620165-22D5F83F-FF5A-4651-B410-7E22378F520CQ37668786-625AD200-532F-4854-A29F-29E9D46BAA84Q37971413-AE345D92-AD2D-4D05-99DA-7CACDDEC8462Q37996771-664850EE-57BF-4126-AD78-2C5E95F66DBCQ38039282-4FD8A681-C685-481D-86B0-41526A8BE105Q38622658-103CC3C9-0CFF-4896-82AB-A28073A01427Q39161614-05B2C5D9-3263-41DC-ABF2-261A1D93F1F1Q39320449-53C8BEDC-9E89-4C85-8AB1-27AC5630B3C8Q39480371-98A58220-3092-4C3D-993B-BDEB432CA5ADQ41049534-DB58ED06-177D-490B-A0D3-8725F0F12B0D
P2860
Phospholipid-esterified eicosanoids are generated in agonist-activated human platelets and enhance tissue factor-dependent thrombin generation.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phospholipid-esterified eicosa ...... dependent thrombin generation.
@ast
Phospholipid-esterified eicosa ...... dependent thrombin generation.
@en
type
label
Phospholipid-esterified eicosa ...... dependent thrombin generation.
@ast
Phospholipid-esterified eicosa ...... dependent thrombin generation.
@en
prefLabel
Phospholipid-esterified eicosa ...... dependent thrombin generation.
@ast
Phospholipid-esterified eicosa ...... dependent thrombin generation.
@en
P2093
P2860
P50
P356
P1476
Phospholipid-esterified eicosa ...... dependent thrombin generation.
@en
P2093
Benjamin H Maskrey
Hartmut Kühn
Hassan A Hamali
Lloyd T Morgan
Peter W Collins
Stanley L Hazen
P2860
P304
P356
10.1074/JBC.M109.078428
P407
P577
2010-01-08T00:00:00Z